Armodafinil for the treatment of excessive sleepiness associated with mild or moderate closed traumatic brain injury: a 12-week, randomized, double-blind study followed by a 12-month open-label extension - Wikidata - awgldk - TriplyDB

Armodafinil for the treatment of excessive sleepiness associated with mild or moderate closed traumatic brain injury: a 12-week, randomized, double-blind study followed by a 12-month open-label extension

Armodafinil for the treatment of excessive sleepiness associated with mild or moderate closed traumatic brain injury: a 12-week, randomized, double-blind study followed by a 12-month open-label extension

http://www.wikidata.org/entity/Q34474531

about

Sleep, Sleep Disorders, and Mild Traumatic Brain Injury. What We Know and What We Need to Know: Findings from a National Working Group Efficacy, Safety, and Tolerability of Armodafinil Therapy for Hypersomnia Associated with Dementia with Lewy Bodies: A Pilot Study.Post-Concussive Syndrome: a Focus on Post-Traumatic Headache and Related Cognitive, Psychiatric, and Sleep Issues.Traumatic Brain Injury, Sleep Disorders, and Psychiatric Disorders: An Underrecognized Relationship.Modafinil for the Improvement of Patient Outcomes Following Traumatic Brain Injury.

P2860

Q28391571-F26B1286-0DED-4C6C-B55E-27CEACD913F3 Q33889663-1EE0AE49-72E8-4FE6-9342-94A8C614E38A Q38973397-2914E65C-4003-4E65-8D68-00ABC676F32C Q49805840-2B2B784B-5B5D-4BE1-839C-BF8D506BC7FB Q54950221-353BE37C-6928-4252-9085-399B4A5CB8CB

P2860

Armodafinil for the treatment of excessive sleepiness associated with mild or moderate closed traumatic brain injury: a 12-week, randomized, double-blind study followed by a 12-month open-label extension

http://www.wikidata.org/entity/Q34474531

description

2014 nî lūn-bûn

@nan

2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

name

Armodafinil for the treatment ...... 12-month open-label extension

@ast

Armodafinil for the treatment ...... 12-month open-label extension

@en

Armodafinil for the treatment ...... 12-month open-label extension

@nl

type

label

Armodafinil for the treatment ...... 12-month open-label extension

@ast

Armodafinil for the treatment ...... 12-month open-label extension

@en

Armodafinil for the treatment ...... 12-month open-label extension

@nl

prefLabel

Armodafinil for the treatment ...... 12-month open-label extension

@ast

Armodafinil for the treatment ...... 12-month open-label extension

@en

Armodafinil for the treatment ...... 12-month open-label extension

@nl

P1433

Q34474531-946EB2BF-1487-454E-861C-C4399CB021E5

P1476

Q34474531-D4512D9C-825C-4329-9195-837753C878CF

P2093

Q34474531-34E63B4E-C876-429D-9436-7E627B1DAD6E

Q34474531-67820316-7ADC-4F39-AC2C-BA4721DAFFD4

Q34474531-8D1E8B35-FBEB-487D-9B2A-BF67340C0935

P2860

Q34474531-0AC1DD39-3D91-4B70-928C-FB3FD90DA353

Q34474531-0F012909-E7C0-4C09-8741-88BA3D144EAF

Q34474531-0FD40C4F-1EF5-4A7B-8753-F8A7E2562030

Q34474531-14731F6C-DD3A-407D-98C6-77E67DA1FC10

Q34474531-1633497E-D2B1-4360-BF77-D8A42AF0DC58

Q34474531-1A09B52D-CDE3-45D8-8289-FF2D22653ADB

Q34474531-2105CBA4-FC3C-4561-AA5E-F55509E9B962

Q34474531-2C3DA040-D0F8-4361-9ED8-9E45FE96CA1C

Q34474531-2D6FA9D1-802B-435D-B222-6B45AF64EB6A

Q34474531-2FD8A0E4-3BBA-4FE2-B10E-0E724101DF2E

P304

Q34474531-CD1058E7-96B3-4DFB-BA81-77AD1A4CB6CC

P31

Q34474531-A5520338-4128-4CC3-B5C1-15100E0613C7

P356

Q34474531-4F8B8E20-B9D8-471E-A4FA-A0AEB13CFF95

P407

Q34474531-49EAE308-5BAD-47B2-A45D-799D142BA580

P433

Q34474531-5BEDAE8D-ECF1-42C3-B551-7A57FC7307EA

P478

Q34474531-207C51DB-53D3-42CE-9832-09CF3E462AA6

P577

Q34474531-6F51AC4B-D2FA-4286-AEB9-EA14D22074AA

P698

Q34474531-A4C30A48-CA17-4E12-950F-8E95DE8ACA34

P921

Q34474531-C0F84BDB-FD80-4986-8D27-C2933A67B81D

P932

Q34474531-14B8EBF6-4740-4D99-AE0C-DF886CF0C843

P356

P1433

The Journal of Clinical Sleep Medicine

P1476

Armodafinil for the treatment ...... 12-month open-label extension

@en

P2093

Alan Lankford

http://www.w3.org/2001/XMLSchema#string

Ronghua Yang

http://www.w3.org/2001/XMLSchema#string

Stuart J Menn

http://www.w3.org/2001/XMLSchema#string

P2860

Armodafinil for treatment of excessive sleepiness associated with shift work disorder: a randomized controlled study.

Efficacy of modafinil on fatigue and excessive daytime sleepiness associated with neurological disorders: a systematic review and meta-analysis

Practice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test.

The improved Clinical Global Impression Scale (iCGI): development and validation in depression

The Clinical Global Impression Scale and the influence of patient or staff perspective on outcome.

Insomnia in patients with traumatic brain injury: frequency, characteristics, and risk factors.

Tolerability and efficacy of armodafinil in naïve patients with excessive sleepiness associated with obstructive sleep apnea, shift work disorder, or narcolepsy: a 12-month, open-label, flexible-dose study with an extension period

The long-term tolerability and efficacy of armodafinil in patients with excessive sleepiness associated with treated obstructive sleep apnea, shift work disorder, or narcolepsy: an open-label extension study.

Guidelines for the multiple sleep latency test (MSLT): a standard measure of sleepiness.

Sleep disturbances and their management in patients with brain injury.

P304

1181-1191

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5664/JCSM.4196

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2014-11-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25325609

http://www.w3.org/2001/XMLSchema#string

P921

traumatic brain injury

P932

4224718

http://www.w3.org/2001/XMLSchema#string